Sponsor

Christopher Sweeney, MBBS

Clinical research sponsor

Published trials2

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

2 shown

Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate CancerNCT00216099 · lead sponsor · 2005-02-01

COMPLETED

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal TherapyNCT00216060 · lead sponsor · 2003-10-01

TERMINATED

Sponsor roles

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.